• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏多糖贮积症的眼部特征:诊断与治疗。

Ocular features in mucopolysaccharidosis: diagnosis and treatment.

机构信息

Pediatric Department, ASST Grande Ospedale Metropolitano Niguarda, Piazza Ospedale Maggiore 3, 20162, Milan, Italy.

Department of Ophthalmology, Ospedale San Gerardo, Via G. B. Pergolesi 33, 20052, Monza, MB, Italy.

出版信息

Ital J Pediatr. 2018 Nov 16;44(Suppl 2):125. doi: 10.1186/s13052-018-0559-9.

DOI:10.1186/s13052-018-0559-9
PMID:30442167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6238255/
Abstract

Mucopolysaccharidoses (MPS) are a group of rare lysosomal storage disorders characterized by the accumulation of glycosaminoglycans (GAGs) in different parts of the eye. Ocular problems are very common in MPS children, and the cornea, sclera, trabecular meshwork, retina, and optic nerve may all be involved. Early diagnosis is very important to preserve the visual function, and the diagnosis requires experience and different evaluations. Follow-up is mandatory to allow a correct pathway to consequent therapy. This article aims to provide a review of ocular alterations and treatment options in MPS. The ophthalmologist is sometimes the first physician who can suspect a metabolic disease and can help to make the correct diagnosis. It is important to stimulate awareness of MPS among ophthalmologists.

摘要

黏多糖贮积症(MPS)是一组罕见的溶酶体贮积症,其特征是在眼睛的不同部位积聚糖胺聚糖(GAG)。眼部问题在 MPS 儿童中非常常见,角膜、巩膜、小梁网、视网膜和视神经都可能受到影响。早期诊断对于保护视力功能非常重要,诊断需要经验和不同的评估。随访是强制性的,以允许后续治疗的正确途径。本文旨在综述 MPS 中的眼部改变和治疗选择。眼科医生有时是第一个能够怀疑代谢疾病并有助于做出正确诊断的医生。重要的是要激发眼科医生对 MPS 的认识。

相似文献

1
Ocular features in mucopolysaccharidosis: diagnosis and treatment.黏多糖贮积症的眼部特征:诊断与治疗。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):125. doi: 10.1186/s13052-018-0559-9.
2
Clinical guidelines for diagnosing and managing ocular manifestations in children with mucopolysaccharidosis.儿童黏多糖贮积症眼部表现的诊断和管理临床指南。
Acta Ophthalmol. 2012 Nov;90(7):595-602. doi: 10.1111/j.1755-3768.2011.02280.x. Epub 2011 Dec 2.
3
Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis.黏多糖贮积症患者眼科特征的诊断与治疗。
Br J Ophthalmol. 2011 May;95(5):613-9. doi: 10.1136/bjo.2010.179937. Epub 2010 Sep 18.
4
Ocular manifestations as key features for diagnosing mucopolysaccharidoses.眼部表现作为诊断黏多糖贮积症的关键特征。
Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v34-40. doi: 10.1093/rheumatology/ker392.
5
Mucopolysaccharidoses and the eye.黏多糖贮积症与眼睛。
Surv Ophthalmol. 2006 Jan-Feb;51(1):1-17. doi: 10.1016/j.survophthal.2005.11.007.
6
An update on ocular involvement in mucopolysaccharidoses.黏多糖贮积症眼部病变的最新进展。
Curr Opin Ophthalmol. 2013 Sep;24(5):379-88. doi: 10.1097/ICU.0b013e3283644ea1.
7
The ocular features of the mucopolysaccharidoses.黏多糖贮积症的眼部特征。
Eye (Lond). 2006 May;20(5):553-63. doi: 10.1038/sj.eye.6701921.
8
Management of Corneal Clouding in Patients with Mucopolysaccharidosis.黏多糖贮积症患者角膜混浊的管理
J Clin Med. 2021 Jul 24;10(15):3263. doi: 10.3390/jcm10153263.
9
Sonographic ocular findings in patients with mucopolysaccharidoses I, II and VI.黏多糖贮积症I型、II型和VI型患者的超声眼部检查结果
Pediatr Radiol. 2008 May;38(5):543-50. doi: 10.1007/s00247-008-0788-y. Epub 2008 Feb 26.
10
Ophthalmologic manifestations in Taiwanese patients with mucopolysaccharidoses.台湾黏多糖贮积症患者的眼科表现
Mol Genet Genomic Med. 2019 May;7(5):e00617. doi: 10.1002/mgg3.617. Epub 2019 Mar 8.

引用本文的文献

1
A novel image-based classification system for atlantoaxial deformity caused by mucopolysaccharidosis type IVA: an efficacy evaluation.一种用于IVA型黏多糖贮积症所致寰枢椎畸形的新型基于图像的分类系统:疗效评估
J Orthop Surg Res. 2025 Jul 15;20(1):656. doi: 10.1186/s13018-025-06085-4.
2
Syndromic Retinitis Pigmentosa: A Narrative Review.综合征性视网膜色素变性:一篇综述
Vision (Basel). 2025 Jan 20;9(1):7. doi: 10.3390/vision9010007.
3
Three-dimensional Evaluation of Gait: Kinetics, Kinematics, and Electromyographic in Patients with Mucopolysacharidosis Types IV and VI.

本文引用的文献

1
Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.两名接受长期酶替代疗法的I型黏多糖贮积症患者出现靶心黄斑病变和黄斑下沉积物。
Am J Ophthalmol Case Rep. 2017 Oct 4;9:1-6. doi: 10.1016/j.ajoc.2017.10.006. eCollection 2018 Mar.
2
Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis.目的 对黏多糖贮积症患者角膜混浊随时间的变化进行量化。
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):954-958. doi: 10.1167/iovs.16-20647.
3
Outcomes of keratoplasty in the mucopolysaccharidoses: an international perspective.
IV型和VI型黏多糖贮积症患者步态的三维评估:动力学、运动学和肌电图分析
Rev Bras Ortop (Sao Paulo). 2024 Jul 22;59(5):e737-e744. doi: 10.1055/s-0044-1786200. eCollection 2024 Oct.
4
Review of clinical trials and guidelines for children and youth with mucopolysaccharidosis: outcome selection and measurement.儿童和青少年黏多糖贮积症的临床试验和指南综述:结局选择和测量。
Orphanet J Rare Dis. 2024 Oct 23;19(1):393. doi: 10.1186/s13023-024-03364-x.
5
Mucopolysaccharidosis Type IIIE: A Real Human Disease or a Diagnostic Pitfall?ⅢE型黏多糖贮积症:一种真实的人类疾病还是诊断陷阱?
Diagnostics (Basel). 2024 Aug 9;14(16):1734. doi: 10.3390/diagnostics14161734.
6
Ocular manifestations of liver disease: an important diagnostic aid.肝脏疾病的眼部表现:重要的诊断辅助手段。
Int Ophthalmol. 2024 Apr 15;44(1):177. doi: 10.1007/s10792-024-03103-y.
7
Transferrin Receptor-Targeted Iduronate-2-sulfatase Penetrates the Blood-Retinal Barrier and Improves Retinopathy in Mucopolysaccharidosis II Mice.转铁蛋白受体靶向艾杜糖-2-硫酸酯酶穿透血视网膜屏障并改善黏多糖贮积症 II 型小鼠的视网膜病变。
Mol Pharm. 2023 Nov 6;20(11):5901-5909. doi: 10.1021/acs.molpharmaceut.3c00736. Epub 2023 Oct 20.
8
In-depth comparison of Anc80L65 and AAV9 retinal targeting and characterization of cross-reactivity to multiple AAV serotypes in humans.Anc80L65与AAV9视网膜靶向的深入比较以及在人类中对多种AAV血清型交叉反应性的表征。
Mol Ther Methods Clin Dev. 2023 May 16;30:16-29. doi: 10.1016/j.omtm.2023.05.016. eCollection 2023 Sep 14.
9
Glycosaminoglycans: Roles in wound healing, formation of corneal constructs and synthetic corneas.糖胺聚糖:在伤口愈合、角膜构建和人工合成角膜中的作用。
Ocul Surf. 2023 Oct;30:85-91. doi: 10.1016/j.jtos.2023.08.008. Epub 2023 Aug 30.
10
Atypical corneal clouding in mucopolysaccharidoses.黏多糖贮积症中的非典型角膜混浊。
Oman J Ophthalmol. 2023 Feb 21;16(1):154-156. doi: 10.4103/ojo.ojo_14_22. eCollection 2023 Jan-Apr.
黏多糖贮积症患者角膜移植的结局:国际视角
Br J Ophthalmol. 2017 Jul;101(7):909-912. doi: 10.1136/bjophthalmol-2016-308807. Epub 2016 Sep 28.
4
Ocular and electrophysiological findings in a patient with Sly syndrome.一名患有斯利综合征患者的眼部及电生理检查结果
Ophthalmic Genet. 2017 Jul-Aug;38(4):376-379. doi: 10.1080/13816810.2016.1214973. Epub 2016 Sep 20.
5
Use of new imaging in detecting and monitoring ocular manifestations of the mucopolysaccharidoses.利用新的影像学方法检测和监测黏多糖贮积症的眼部表现。
Acta Ophthalmol. 2016 Dec;94(8):e676-e682. doi: 10.1111/aos.13098. Epub 2016 Jun 8.
6
Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses.溶酶体贮积症的眼部表现及管理建议I:黏多糖贮积症
Clin Ophthalmol. 2015 Sep 7;9:1633-44. doi: 10.2147/OPTH.S78368. eCollection 2015.
7
The natural history of MPS I: global perspectives from the MPS I Registry.黏多糖贮积症 I 型的自然病史:来自黏多糖贮积症 I 型注册库的全球视角
Genet Med. 2014 Oct;16(10):759-65. doi: 10.1038/gim.2014.25. Epub 2014 Mar 27.
8
An update on ocular involvement in mucopolysaccharidoses.黏多糖贮积症眼部病变的最新进展。
Curr Opin Ophthalmol. 2013 Sep;24(5):379-88. doi: 10.1097/ICU.0b013e3283644ea1.
9
Measuring corneal clouding in patients suffering from mucopolysaccharidosis with the Pentacam densitometry programme.应用 Pentacam 密度测定程序测量黏多糖贮积症患者的角膜混浊度。
Br J Ophthalmol. 2013 Jul;97(7):829-33. doi: 10.1136/bjophthalmol-2012-302913. Epub 2013 May 17.
10
Ocular manifestations as key features for diagnosing mucopolysaccharidoses.眼部表现作为诊断黏多糖贮积症的关键特征。
Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v34-40. doi: 10.1093/rheumatology/ker392.